Insilico Medicine

Insilico Medicine is a leading global biotech company pioneering the use of generative artificial intelligence (AI) in drug discovery and development. Their mission is to extend healthy, productive longevity by significantly reducing the time and cost of bringing life-saving medications to patients. They have built a fully integrated, AI-driven platform called Pharma.AI, which leverages their expertise in biology, chemistry, and clinical development. This platform has resulted in a diversified internal pipeline of 31 programs targeting 29 drug targets, with seven programs currently in clinical stages.

Insilico Medicine has demonstrated the power of their AI-driven approach through a number of notable achievements. They have advanced the first generative AI-designed drug to human clinical trials and achieved a historical precedent by bringing an AI-discovered molecule based on an AI-discovered novel target to clinical trials in under 30 months. In addition to their internal pipeline, they have numerous partnerships with leading pharmaceutical companies and academic institutions, furthering their goal of revolutionizing the drug discovery process.

Insilico Medicine is a global, clinical-stage, end-to-end, generative artificial intelligence (AI)-driven biotech company with a mission to accelerate drug discovery and development by leveraging its proprietary Pharma.AI platform across biology, chemistry and clinical development. This generative AI platform enables Insilico to rapidly and efficiently advance its fully self-generated AI-driven drug discovery (AIDD) pipeline, primarily composed of novel drug candidates.

Insilico Medicine fosters a culture of innovation and collaboration, driven by the pursuit of extending healthy longevity through AI-powered drug discovery. The company prioritizes transparency, integrity, and relentless innovation, while embracing a global presence and fostering strong partnerships with leading industry partners and investors. This results in a dynamic and fast-paced environment that values diverse perspectives and encourages its employees to be at the forefront of scientific advancement.

Insilico Medicine is committed to building a diverse, equitable and inclusive workplace that fosters a sense of belonging for all employees. They have a global presence with teams in the U.S., Greater China, Canada, and the Middle East, allowing them to recruit top scientific talent from diverse backgrounds. This commitment to diversity is reflected in their team composition, which includes individuals from various nationalities, ethnicities, and gender identities. The company also seeks to foster an environment of respect and inclusion, where all voices are valued and individuals are encouraged to bring their unique perspectives and experiences to the table.